Detalhe da pesquisa
1.
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
Circulation
; 146(16): 1196-1206, 2022 10 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36030390
2.
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial.
Lancet
; 400(10357): 997-1007, 2022 09 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36063821
3.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
N Engl J Med
; 378(23): 2191-2201, 2018 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29766772
4.
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
J Stroke Cerebrovasc Dis
; 27(6): 1673-1682, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29525076
5.
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
Am Heart J
; 178: 126-34, 2016 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-27502860
6.
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
Am Heart J
; 169(4): 464-71.e2, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25819852
7.
Efficacy of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen in women with moderate-to-severe primary dysmenorrhoea: an open-label, multicentre, randomised, controlled study.
J Fam Plann Reprod Health Care
; 38(2): 94-101, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22454006
8.
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.
Ther Innov Regul Sci
; 54(3): 507-518, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33301136
9.
A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies.
Ther Innov Regul Sci
; : 2168479019853782, 2019 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31204501
10.
Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.
J Pediatr Adolesc Gynecol
; 30(5): 560-567, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28189702
11.
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial.
Eur Stroke J
; 1(3): 146-154, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31008276
12.
Adherence with ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen supported by the use of a digital tablet dispenser with or without acoustic alarm: an open-label, randomized, multicenter study.
Int J Womens Health
; 7: 19-29, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25609999
13.
Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden.
Cardiol Ther
; 4(2): 131-53, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26099515